|
Martinez-Vicente I, Abrisqueta M, Herraiz C, Sires-Campos J, Castejon-Grinan M, Bennett DC, Olivares C, Garcia-Borron JC, Jimenez-Cervantes C. Mahogunin Ring Finger 1 Is Required for Genomic Stability and Modulates the Malignant Phenotype of Melanoma Cells. Cancers (Basel). 2020 Oct 1;12(10):2840. doi: 10.3390/cancers12102840. PubMed PMID: 33019669; PubMed Central PMCID: PMC7599452.
AÑO: 2020; IF: 6.575
|
33019669
|
Martinez-Morcillo FJ, Canton-Sandoval J, Martinez-Navarro FJ, Cabas I, Martinez-Vicente I, Armistead J, Hatzold J, Lopez-Munoz A, Martinez-Menchon T, Corbalan-Velez R, Lacal J, Hammerschmidt M, Garcia-Borron JC, Garcia-Ayala A, Cayuela ML, Perez-Oliva AB, Garcia-Moreno D, Mulero V. NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death. PLoS Biol. 2021 Nov 8;19(11):e3001455. doi: 10.1371/journal.pbio.3001455. eCollection 2021 Nov. PubMed PMID: 34748530; PubMed Central PMCID: PMC8601609.
AÑO: 2021; IF: 9.593
|
|
Abrisqueta M, Cerdido S, Sanchez-Beltran J, Martinez-Vicente I, Herraiz C, Lambertos A, Olivares C, Sevilla A, Alonso S, Boyano MD, Garcia-Borron JC, Jimenez-Cervantes C. MGRN1 as a Phenotypic Determinant of Human Melanoma Cells and a Potential Biomarker. Life (Basel). 2022 Jul 26;12(8):1118. doi: 10.3390/life12081118. PubMed PMID: 35892921; PubMed Central PMCID: PMC9331370.
AÑO: 2022; IF: 3.251
|
|
Cerdido S, Abrisqueta M, Sanchez-Beltran J, Lambertos A, Castejon-Grinan M, Munoz C, Olivares C, Garcia-Borron JC, Jimenez-Cervantes C, Herraiz C. MGRN1 depletion promotes intercellular adhesion in melanoma by upregulation of E-cadherin and inhibition of CDC42. Cancer Lett. 2024 Jan 28;581:216484. doi: 10.1016/j.canlet.2023.216484. Epub 2023 Nov 25. PubMed PMID: 38008393.
AÑO: 2024; IF: 10.1
|
|
Sánchez-Beltrán J., Soler Díaz J., Herraiz C., Olivares C., Cerdido S., Cerezuela-Fuentes P., García-Borrón J.C., Jiménez-Cervantes C. An MGRN1-Based Biomarker Combination Accurately Predicts Melanoma Patient Survival. International Journal of Molecular Sciences. February 2025. 26. 10.3390/ijms26041739
AÑO: 2025; IF: 4.9
|